Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02091245
Title Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute biphenotypic leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

leukemia

chronic myeloid leukemia

Therapies

Selinexor

Age Groups: child
Covered Countries USA


No variant requirements are available.